[1]
D. Piciu, C. Pestean, E. Barbus, M. I. Larg, and A. Piciu, “Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131”, Med Pharm Rep, vol. 89, no. 3, pp. 384–389, Jul. 2016.